國立虎尾科技大學 |

Vaccines for biodefense and emerging and neglected diseases

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Vaccines for biodefense and emerging and neglected diseases/ edited by Alan D.T. Barrett, Lawrence R. Stanberry.
other author:	Barrett, A. D. T.
Published:	Amsterdam ;Academic, : 2009.,
Description:	1 online resource (xxvii, 1478 p., [12] p. of plates) :ill. (some col.), maps (some col.) :
Subject:	Vaccines. -
Online resource:	An electronic book accessible through the World Wide Web; click for information
ISBN:	9780123694089

Vaccines for biodefense and emerging and neglected diseases
Vaccines for biodefense and emerging and neglected diseases[electronic resource] /edited by Alan D.T. Barrett, Lawrence R. Stanberry. - 1st ed. - Amsterdam ;Academic,2009. - 1 online resource (xxvii, 1478 p., [12] p. of plates) :ill. (some col.), maps (some col.)

Includes bibliographical references and index.

Agents of Emerging Infectious Diseases; Bacterial biothreats agents; Viral Biothreat agents; Vaccine Development Pathway; Immunology of Vaccines; Molecular Approches to Bacterial Vaccines; Viral Vectors; DNA Vaccines; Vaccine Adjuvants; Preclinical Vaccine Development; Vaccine Manufacturing; Clinical Trials of Vaccines; Pre-IND/IND Process; Regulatory Issues-USA; Special Issues around Veterinary Vaccines; Vaccines Misinformation; Vaccine for Military Application; Dengue; Filoviruses; Alphaviral Encephalitides; Foot & Mouth; Hantaviruses; -- Hepatitis; HIV; Human papillomavirus; Influenza; Japanese encephalitis; Junin & other Arenaviruses; Measles; Nipah and Hendra; O'Nyong, N'yong, and Chikungunya Viruses; Rabies; Ross River Virus; Rotavirus; SARS; Smallpox; Tick Borne Encephalitis; West Nile Virus; Yellow Fever; Anthrax; Brucellosis; Burkholderia mallei and Burkholderia pseudomallei; Chlamydia; Cholea; Botulinum; Erlichia; Extraintestinal pathogenic E. coli; Gonnorhea; Helicobactor pylori; Intestinal pathogenic E. coli; Lyme Disease; Niesseria meningitidis; Plague; Ricin-a toxin; Rickettsia; Salmonella; Shigella; Syphilis; Tuberculosis; Tularemia; African trypanosomiasis; Leishmaniasis; Leptospirosis; Malaria; Hookworm; Onchocerciasis; Schistosomiasis; American Trypanosomiasis.

The last 20 years has seen a rapid increase in infectious diseases, particularly those that are termed "emerging diseases" such as SARS, "neglected diseases" such as malaria and those that are deemed biothreats such as anthrax. It is well-recognized that the most effective modality for preventing infectious diseases is vaccination. This book provides researchers with a better understanding of what is currently known about these diseases, including whether there is a vaccine available or under development. It also informs them of what they need to do if they are currently working on developing a vaccine. * Provides a comprehensive treatise of the agents that are responsible for emerging and neglected diseases and those that can be used as biothreats * Includes the processes such as the vaccine development pathway, vaccine manufacturing and regulatory issues that are critical to the generation of these vaccines to the marketplace * Each chapter will include a map of the world showing where that particular disease is naturally found.

ISBN: 9780123694089

Source: 113375:113465Elsevier Science & Technologyhttp://www.sciencedirect.comSubjects--Topical Terms:

582184
Vaccines.
Index Terms--Genre/Form:

554714
Electronic books.

LC Class. No.: RA643 / .V33 2009

Dewey Class. No.: 614.47

National Agricultural Library Call No.: RA643 / .V33 2009

National Library of Medicine Call No.: 2009 C-124

Vaccines for biodefense and emerging and neglected diseases
LDR:03821cam 2200385Ia 4500 001 679542
003 OCoLC
005 20110614113933.0
006 m d
007 cr cn|||||||||
008 111108s2008 enkabf ob 001 0 eng d
019 $a 316567007 $a 370376591
020 $a 9780123694089
020 $a 0123694086
029 1 $a HEBIS $b 246726776
035 $a (OCoLC)246733059 $z (OCoLC)316567007 $z (OCoLC)370376591
035 $a ocn246733059
037 $a 113375:113465 $b Elsevier Science & Technology $n http://www.sciencedirect.com
040 $a OPELS $b eng $c OPELS $d OPELS $d OCLCQ $d FUH $d BTCTA $d OCLCQ
049 $a TEFA
050 4 $a RA643 $b .V33 2009
060 4 $a 2009 C-124
060 4 $a QW 805 $b V11642 2009
070 1 $a RA643 $b .V33 2009
082 0 4 $a 614.47 $2 22
245 0 0 $a Vaccines for biodefense and emerging and neglected diseases $h [electronic resource] / $c edited by Alan D.T. Barrett, Lawrence R. Stanberry.
250 $a 1st ed.
260 $a Amsterdam ; $a Boston : $b Academic, $c 2009.
300 $a 1 online resource (xxvii, 1478 p., [12] p. of plates) : $b ill. (some col.), maps (some col.)
504 $a Includes bibliographical references and index.
505 0 $a Agents of Emerging Infectious Diseases; Bacterial biothreats agents; Viral Biothreat agents; Vaccine Development Pathway; Immunology of Vaccines; Molecular Approches to Bacterial Vaccines; Viral Vectors; DNA Vaccines; Vaccine Adjuvants; Preclinical Vaccine Development; Vaccine Manufacturing; Clinical Trials of Vaccines; Pre-IND/IND Process; Regulatory Issues-USA; Special Issues around Veterinary Vaccines; Vaccines Misinformation; Vaccine for Military Application; Dengue; Filoviruses; Alphaviral Encephalitides; Foot & Mouth; Hantaviruses; -- Hepatitis; HIV; Human papillomavirus; Influenza; Japanese encephalitis; Junin & other Arenaviruses; Measles; Nipah and Hendra; O'Nyong, N'yong, and Chikungunya Viruses; Rabies; Ross River Virus; Rotavirus; SARS; Smallpox; Tick Borne Encephalitis; West Nile Virus; Yellow Fever; Anthrax; Brucellosis; Burkholderia mallei and Burkholderia pseudomallei; Chlamydia; Cholea; Botulinum; Erlichia; Extraintestinal pathogenic E. coli; Gonnorhea; Helicobactor pylori; Intestinal pathogenic E. coli; Lyme Disease; Niesseria meningitidis; Plague; Ricin-a toxin; Rickettsia; Salmonella; Shigella; Syphilis; Tuberculosis; Tularemia; African trypanosomiasis; Leishmaniasis; Leptospirosis; Malaria; Hookworm; Onchocerciasis; Schistosomiasis; American Trypanosomiasis.
520 $a The last 20 years has seen a rapid increase in infectious diseases, particularly those that are termed "emerging diseases" such as SARS, "neglected diseases" such as malaria and those that are deemed biothreats such as anthrax. It is well-recognized that the most effective modality for preventing infectious diseases is vaccination. This book provides researchers with a better understanding of what is currently known about these diseases, including whether there is a vaccine available or under development. It also informs them of what they need to do if they are currently working on developing a vaccine. * Provides a comprehensive treatise of the agents that are responsible for emerging and neglected diseases and those that can be used as biothreats * Includes the processes such as the vaccine development pathway, vaccine manufacturing and regulatory issues that are critical to the generation of these vaccines to the marketplace * Each chapter will include a map of the world showing where that particular disease is naturally found.
588 $a Description based on print version record.
650 0 $a Vaccines. $3 582184
650 0 $a Communicable diseases $x Prevention. $3 782684
650 0 $a Communicable diseases $x Epidemiology. $3 788903
650 1 2 $a Communicable Disease Control. $3 788904
650 1 2 $a Communicable Diseases, Emerging $x prevention & control. $3 788905
650 2 2 $a Bioterrorism $x prevention & control. $3 788771
650 2 2 $a Communicable Diseases $x epidemiology. $3 579519
655 4 $a Electronic books. $2 local $3 554714
700 1 $a Barrett, A. D. T. $q (Alan D. T.) $3 788902
700 1 $a Stanberry, Lawrence R. $3 635636
710 2 $a ScienceDirect (Online service) $3 636041
856 4 0 $3 ScienceDirect $u http://www.sciencedirect.com/science/book/9780123694089 $z An electronic book accessible through the World Wide Web; click for information
938 $a Baker and Taylor $b BTCP $n BK0007846738
994 $a C0 $b TEF